News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
66,618 Results
Type
Article (2291)
Company Profile (111)
Press Release (64216)
Section
Business (27942)
Career Advice (33)
Deals (4198)
Drug Delivery (6)
Drug Development (6372)
Employer Resources (1)
FDA (1286)
Job Trends (1222)
News (38247)
Policy (2047)
Tag
Academia (90)
Allergies (9)
Alliances (2366)
ALS (7)
Alzheimer's disease (152)
Antibody-drug conjugate (ADC) (11)
Approvals (1297)
Artificial intelligence (15)
Autoimmune disease (2)
Automation (1)
Bankruptcy (16)
Best Places to Work (1208)
Biosimilars (3)
Biotechnology (78)
Bladder cancer (22)
Brain cancer (3)
Breast cancer (24)
Cancer (211)
Cardiovascular disease (18)
Career advice (31)
Career pathing (2)
CAR-T (11)
Cell therapy (38)
Cervical cancer (3)
Clinical research (5519)
Collaboration (41)
Compensation (31)
COVID-19 (185)
CRISPR (4)
C-suite (10)
Cystic fibrosis (15)
Data (312)
Depression (3)
Diabetes (26)
Diagnostics (664)
Digital health (5)
Drug discovery (7)
Drug pricing (3)
Duchenne muscular dystrophy (6)
Earnings (24188)
Editorial (1)
Employer resources (1)
Events (7873)
Executive appointments (28)
FDA (1465)
Frontotemporal dementia (2)
Funding (49)
Gene editing (9)
Generative AI (1)
Gene therapy (24)
GLP-1 (51)
Government (177)
Guidances (79)
Healthcare (1953)
Huntington's disease (1)
Immunology and inflammation (12)
Indications (2)
Infectious disease (194)
Inflammatory bowel disease (6)
Influenza (1)
Intellectual property (7)
Interviews (1)
IPO (3097)
IRA (1)
Job creations (123)
Job search strategy (28)
Kidney cancer (2)
Labor market (4)
Layoffs (12)
Legal (350)
Liver cancer (5)
Lung cancer (25)
Lymphoma (25)
Machine learning (1)
Manufacturing (14)
MASH (8)
Medical device (1713)
Medtech (1713)
Mergers & acquisitions (1158)
Metabolic disorders (74)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (4)
Neuropsychiatric disorders (2)
Neuroscience (194)
NextGen: Class of 2025 (466)
Non-profit (185)
Obesity (39)
Opinion (2)
Ovarian cancer (2)
Pain (10)
Pancreatic cancer (3)
Parkinson's disease (14)
Partnered (2)
Patents (20)
Patient recruitment (5)
Peanut (3)
People (2268)
Pharmaceutical (19)
Pharmacy benefit managers (1)
Phase I (1296)
Phase II (2290)
Phase III (2343)
Pipeline (495)
Policy (2)
Postmarket research (167)
Preclinical (517)
Press Release (2)
Prostate cancer (9)
Radiopharmaceuticals (16)
Rare diseases (37)
Real estate (293)
Recruiting (1)
Regulatory (1628)
Reports (6)
Research institute (91)
Rett syndrome (2)
RSV (6)
Schizophrenia (11)
Series A (4)
Series B (1)
Service/supplier (2)
Sickle cell disease (2)
Special edition (2)
Spinal muscular atrophy (8)
Sponsored (1)
Startups (143)
Supply chain (1)
Tariffs (1)
Vaccines (57)
Venture capitalists (2)
Weight loss (20)
Women's health (4)
Date
Today (38)
Last 7 days (214)
Last 30 days (439)
Last 365 days (4212)
2025 (1516)
2024 (4608)
2023 (5123)
2022 (6287)
2021 (6992)
2020 (6114)
2019 (4021)
2018 (3225)
2017 (3062)
2016 (2113)
2015 (2983)
2014 (2090)
2013 (1583)
2012 (1809)
2011 (1986)
2010 (1699)
Location
Africa (40)
Alabama (3)
Arizona (10)
Asia (2991)
Australia (627)
California (1046)
Canada (230)
China (27)
Colorado (41)
Connecticut (33)
Delaware (21)
Europe (8243)
Florida (118)
Georgia (39)
Idaho (1)
Illinois (54)
India (1)
Indiana (42)
Japan (33)
Kansas (49)
Kentucky (3)
Louisiana (4)
Maine (15)
Maryland (80)
Massachusetts (611)
Michigan (34)
Minnesota (41)
Mississippi (1)
Missouri (5)
Montana (6)
Nevada (10)
New Hampshire (10)
New Jersey (299)
New York (210)
North Carolina (103)
Northern California (422)
Ohio (16)
Oregon (3)
Pennsylvania (154)
South America (77)
South Carolina (1)
Southern California (383)
Tennessee (7)
Texas (84)
United States (3205)
Utah (43)
Virginia (27)
Washington D.C. (3)
Washington State (61)
Wisconsin (5)
66,618 Results for "94".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Interim Report January-March 2025: 94 Percent Growth
April 22, 2025
·
3 min read
Press Releases
bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024
April 1, 2025
·
11 min read
Cardiovascular disease
Lilly’s RNA Silencer Lowers Key Cardiovascular Biomarker by Almost 94%
BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in development to date” in the competitive Lp(a) space, where drugs are designed to lower the risk of cardiovascular events such as heart attack and stroke.
March 31, 2025
·
2 min read
·
Tristan Manalac
Obesity
Aardvark Therapeutics Gets $94 Million IPO to Power Obesity Treatments
Obesity drug developers Aardvark, Helicore and Metsera have all netted raises in the past two weeks.
February 13, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
U.S. Medical Device Outsourcing Market Size to Reach USD 94.80 Bn By 2034
February 25, 2025
·
1 min read
Press Releases
Liquid Biopsy Market Size Surges 14.5% CAGR to Soar $23.94 Billion by 2034
February 20, 2025
·
1 min read
Press Releases
Lilly’s lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels
March 31, 2025
·
8 min read
Press Releases
Leukocyte Disorders Market Size to Reach USD 94.6 Billion by 2035, Impelled by Advancements in Gene Therapies
February 6, 2025
·
11 min read
Business
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments.
April 26, 2024
·
9 min read
Biotech Bay
Firefly Bio Debuts With $94 Million Series A Financing
Firefly Bio emerged from stealth mode with a $94 million Series A financing co-led by founding investor Versant Ventures and by MPM BioImpact alongside Decheng Capital and with participation from Eli Lilly & Company.
February 15, 2024
·
6 min read
1 of 6,662
Next
